Ionis Pharmaceuticals (IONS) Land & Improvements (2011 - 2014)
Ionis Pharmaceuticals (IONS) posted quarterly Land & Improvements of $10.2 million for Q4 2014, little changed year-over-year from $10.2 million in Q4 2013, and little changed quarter-over-quarter from $10.2 million in Q4 2013.
Ionis Pharmaceuticals (IONS) Land & Improvements (2011 - 2014) Analysis & Trends
Ionis Pharmaceuticals' Land & Improvements history runs 4 years deep, the most recent figure standing at $10.2 million for Q4 2014.
- In Q4 2014, Land & Improvements changed 0.0% year-over-year to $10.2 million; the TTM figure through Dec 2014 stood at $10.2 million (changed 0.0% YoY), while the FY2014 annual figure was $10.2 million, changed 0.0% from the prior year.
- Land & Improvements for Q4 2014 stood at $10.2 million, roughly flat from $10.2 million in the prior quarter.
- The five-year high for Land & Improvements was $10.2 million in Q4 2011, with the low at $10.2 million in Q4 2011.
- The 4-year median for Land & Improvements is $10.2 million (2011), against an average of $10.2 million.
- Peak annual rise in Land & Improvements reached 0.0% in 2012, while the deepest fall reached 0.0% in 2012.
- Ionis Pharmaceuticals' Land & Improvements stood at $10.2 million in 2011, then changed by 0.0% to $10.2 million in 2012, then changed by 0.0% to $10.2 million in 2013, then changed by 0.0% to $10.2 million in 2014.
- Business Quant data shows IONS's Land & Improvements at $10.2 million in Q4 2014, $10.2 million in Q4 2013, and $10.2 million in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 10.20 Mn |
| Dec 31, 2013 | 10.20 Mn |
| Dec 31, 2012 | 10.20 Mn |
| Dec 31, 2011 | 10.20 Mn |